Przegląd Epidemiologiczny - Państwowy Zakład Higieny

Index Copernicus 5,58Epidemiological ReviewQUARTERLYJOURNAL OF THE NATIONAL INSTITUTE OF PUBLIC HEALTH– NATIONAL INSTITUTE OF HYGIENEAND THE POLISH SOCIETY OF EPIDEMIOLOGY AND INFECTIOUS DISEASESVOLUME 66 2012 no 1contentsAbstracts: www.pzh.gov.pl/przeglad_epimedPROBLEMS OF INFECTIONSA Kopacz, A Bielecka, M Mikulska, P Grabarczyk, P Zwolińska, B Wojciechowska, M Łętowska, EKisiel, K Warzocha, B Ceglarek, A B Szczepanik, A Szczepiński, K Owczarska, K Pielaciński, EBrojer: Analysis of the prevalence of HBV markers relevant to the risk of reactivation of infectionin patients with hematologic diseases ........................................................................................................ 1P Grabarczyk, J Korzeniowska, G Liszewski, A Kalińska, E Sułkowska, M Krug-Janiak, A Kopacz, MŁętowska, E Brojer: Testing of DNA of parvovirus B19 in Polish blood donors, 2004-2010 ................. 7P Zalas-Więcek, E Gospodarek, J Wróblewska: Occurence and antimicrobial susceptibility of Morganellamorganii strains isolated from clinical samples .................................................................................. 13J Filipiuk, A Nowicka-Ciełuszecka, J Tarasiuk, S Pancewicz: Occurrence of Erythema migrans in Hajnowkadistrict in years 2004-2010 ........................................................................................................... 19T W Łapiński, J Jaroszewicz, A Ostapczuk, R Flisiak: Chronic HBV infection in patients with lymphoproliferativesyndromes ........................................................................................................................... 25K Szwabowicz, A Panasiuk: Carrier-state of group B Streptococcus in pregnant women – performancestandards ................................................................................................................................................. 33A Chojecka, K Jakubiec, B Jakimiak, E Rohm-Rodowald, K Kanclerski: Significance of the efflux phenomenonas a mechanism of bacterial resistance on active substances of biocide ................................. 39* * **D Dybowska, D Kozielewicz, W Halota: Forecasting of efficacy of chronic hepatitis B therapy .................. 45*D Kozielewicz, W Halota, D Dybowska: Efficacy of triple therapy in patients not treated and patientspreviously treated ineffectively ............................................................................................................... 49*M Pawłowska, A Olczak: HCV protease inhibitors and drug resistance ......................................................... 55*A Olczak, E Grąbczewska: Clostridium difficile as etiological agent of pseudomembranous colitis ............. 59*K Dulęba, E Smukalska, M Pawłowska: Clostridium difficile infection in children – experienceof Clinical Centre in Bydgoszcz .................................................................................................... 67*K Simon, J Janocha: Epidemic of EHEC (Escherichia coli O104:44) in Europe in 2011 – clinical andtherapeutic problems ................................................................................................................................ 73*A Olczak, E Grąbczewska: HIV preexposure prophylaxis .............................................................................. 79* W Halota, R Flisiak, A Boroń-Kaczmarska, J Juszczyk, J Cianciara, M Pawłowska, K Simon,P Małkowski: Standards of hepatitis C treatment. Recommendations of Polish Group of Experts ........ 83*Scientific Conference “Infectious diseases on the start next decade”, Bydgoszcz, 22-24.09.2011